• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞衰老在癌症中的亦正亦邪。

The Jekyll and Hyde of Cellular Senescence in Cancer.

机构信息

Izmir Biomedicine and Genome Center, Izmir 35340, Turkey.

Izmir International Biomedicine and Genome Institute, Dokuz Eylul University, Izmir 35340, Turkey.

出版信息

Cells. 2021 Jan 21;10(2):208. doi: 10.3390/cells10020208.

DOI:10.3390/cells10020208
PMID:33494247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7909764/
Abstract

Cellular senescence is a state of stable cell cycle arrest that can be triggered in response to various insults and is characterized by distinct morphological hallmarks, gene expression profiles, and the senescence-associated secretory phenotype (SASP). Importantly, cellular senescence is a key component of normal physiology with tumor suppressive functions. In the last few decades, novel cancer treatment strategies exploiting pro-senescence therapies have attracted considerable interest. Recent insight, however, suggests that therapy-induced senescence (TIS) elicits cell-autonomous and non-cell-autonomous implications that potentially entail detrimental consequences, reflecting the Jekyll and Hyde nature of cancer cell senescence. In essence, the undesirable manifestations that generally culminate in inflammation, cancer stemness, senescence reversal, therapy resistance, and disease recurrence are dictated by the persistent accumulation of senescent cells and the SASP. Thus, mitigating these pro-tumorigenic effects by eliminating these cells or inhibiting their SASP production holds great promise for developing innovative therapeutic strategies. In this review, we describe the fundamental aspects and dynamics of cancer cell senescence and summarize the comprehensive research on the adverse outcomes of TIS. Furthermore, we underline the rationale and motivation of emerging senotherapeutic modalities surrounding the removal of senescent cells and the SASP to help maximize the overall efficacy of cancer therapies.

摘要

细胞衰老是一种稳定的细胞周期停滞状态,可以响应各种损伤而被触发,其特征是具有独特的形态特征、基因表达谱和衰老相关分泌表型(SASP)。重要的是,细胞衰老作为一种正常生理过程的关键组成部分,具有肿瘤抑制功能。在过去的几十年中,利用促衰老疗法的新型癌症治疗策略引起了相当大的兴趣。然而,最近的研究表明,治疗诱导的衰老(TIS)引发了细胞自主性和非细胞自主性的影响,可能会产生有害的后果,反映了癌细胞衰老的ekyll 和 Hyde 性质。从本质上讲,通常最终导致炎症、癌症干性、衰老逆转、治疗抵抗和疾病复发的不良表现是由衰老细胞和 SASP 的持续积累决定的。因此,通过消除这些细胞或抑制其 SASP 的产生来减轻这些促肿瘤效应,为开发创新的治疗策略提供了巨大的希望。在这篇综述中,我们描述了癌细胞衰老的基本方面和动力学,并总结了关于 TIS 的不良后果的全面研究。此外,我们强调了新兴的衰老治疗方法的原理和动机,即清除衰老细胞和 SASP,以帮助最大限度地提高癌症治疗的整体疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f93/7909764/33e71c1ca9f1/cells-10-00208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f93/7909764/822f4771c0e0/cells-10-00208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f93/7909764/1e0b868abb68/cells-10-00208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f93/7909764/33e71c1ca9f1/cells-10-00208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f93/7909764/822f4771c0e0/cells-10-00208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f93/7909764/1e0b868abb68/cells-10-00208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f93/7909764/33e71c1ca9f1/cells-10-00208-g003.jpg

相似文献

1
The Jekyll and Hyde of Cellular Senescence in Cancer.细胞衰老在癌症中的亦正亦邪。
Cells. 2021 Jan 21;10(2):208. doi: 10.3390/cells10020208.
2
Therapy-Induced Cellular Senescence: Potentiating Tumor Elimination or Driving Cancer Resistance and Recurrence?治疗诱导的细胞衰老:增强肿瘤消除或导致癌症耐药和复发?
Cells. 2024 Jul 30;13(15):1281. doi: 10.3390/cells13151281.
3
Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.衰老相关分泌表型的促肿瘤和抑肿瘤功能。
Expert Opin Ther Targets. 2019 Dec;23(12):1041-1051. doi: 10.1080/14728222.2019.1565658. Epub 2019 Jan 15.
4
Senescent cells in cancer therapy: why and how to remove them.衰老细胞在癌症治疗中的作用:为什么以及如何清除它们。
Cancer Lett. 2021 Nov 1;520:68-79. doi: 10.1016/j.canlet.2021.07.002. Epub 2021 Jul 5.
5
Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer.克服衰老相关分泌表型 (SASP):癌症治疗中耐药的复杂机制。
Mol Oncol. 2021 Dec;15(12):3242-3255. doi: 10.1002/1878-0261.13042. Epub 2021 Jul 12.
6
Senescence and the SASP: many therapeutic avenues.衰老和 SASP:多种治疗途径。
Genes Dev. 2020 Dec 1;34(23-24):1565-1576. doi: 10.1101/gad.343129.120.
7
The role of senescence in cancer development.衰老在癌症发展中的作用。
Semin Cancer Biol. 2020 May;62:182-191. doi: 10.1016/j.semcancer.2019.06.018. Epub 2019 Jun 28.
8
Spatial and Temporal Control of Senescence.衰老的时空控制。
Trends Cell Biol. 2017 Nov;27(11):820-832. doi: 10.1016/j.tcb.2017.07.004. Epub 2017 Aug 17.
9
Targeting tumor cell senescence and polyploidy as potential therapeutic strategies.靶向肿瘤细胞衰老和多倍体化为潜在的治疗策略。
Semin Cancer Biol. 2022 Jun;81:37-47. doi: 10.1016/j.semcancer.2020.12.010. Epub 2020 Dec 20.
10
Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).评估衰老相关分泌表型(SASP)的功能作用。
Methods Mol Biol. 2019;1896:45-55. doi: 10.1007/978-1-4939-8931-7_6.

引用本文的文献

1
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons.氧化应激驱动的细胞衰老:机制串扰与治疗前景
Antioxidants (Basel). 2025 Aug 12;14(8):987. doi: 10.3390/antiox14080987.
2
Unveiling the therapeutic potential of senescence-related IQGAP2 in pancreatic Cancer through post-GWAS genomic and scRNA-seq analyses.通过全基因组关联研究(GWAS)后的基因组和单细胞RNA测序(scRNA-seq)分析揭示衰老相关IQGAP2在胰腺癌中的治疗潜力。
Discov Oncol. 2025 Jul 10;16(1):1301. doi: 10.1007/s12672-025-03078-x.
3
Cellular senescence in the tumor with a bone niche microenvironment: friend or foe?

本文引用的文献

1
Molybdenum Disulfide Nanoparticles Resist Oxidative Stress-Mediated Impairment of Autophagic Flux and Mitigate Endothelial Cell Senescence and Angiogenic Dysfunctions.二硫化钼纳米颗粒抵抗氧化应激介导的自噬通量损伤,并减轻内皮细胞衰老和血管生成功能障碍。
ACS Biomater Sci Eng. 2018 Feb 12;4(2):663-674. doi: 10.1021/acsbiomaterials.7b00714. Epub 2018 Jan 3.
2
Senescence and the SASP: many therapeutic avenues.衰老和 SASP:多种治疗途径。
Genes Dev. 2020 Dec 1;34(23-24):1565-1576. doi: 10.1101/gad.343129.120.
3
Metformin as a senostatic drug enhances the anticancer efficacy of CDK4/6 inhibitor in head and neck squamous cell carcinoma.
具有骨龛微环境的肿瘤中的细胞衰老:朋友还是敌人?
Clin Exp Med. 2025 Jan 23;25(1):44. doi: 10.1007/s10238-025-01564-8.
4
Resistance to spindle inhibitors in glioblastoma depends on STAT3 and therapy induced senescence.胶质母细胞瘤对纺锤体抑制剂的耐药性取决于信号转导和转录激活因子3(STAT3)以及治疗诱导的衰老。
iScience. 2024 Nov 5;27(12):111311. doi: 10.1016/j.isci.2024.111311. eCollection 2024 Dec 20.
5
Cellular senescence in Alzheimer's disease: from physiology to pathology.阿尔茨海默病中的细胞衰老:从生理学到病理学。
Transl Neurodegener. 2024 Nov 20;13(1):55. doi: 10.1186/s40035-024-00447-4.
6
The Senolytic Effect of Indole-3-Carbinol (I3C) on Mouse Embryonic (MEF) and Human Fibroblast Cell Lines.吲哚-3-甲醇 (I3C) 对小鼠胚胎成纤维细胞 (MEF) 和人成纤维细胞系的衰老细胞选择性杀伤作用。
Int J Mol Sci. 2024 Oct 30;25(21):11652. doi: 10.3390/ijms252111652.
7
Furan-rich, biobased transfection agents as potential oligomeric candidates for intracellular plasmid DNA delivery.富含呋喃的生物基转染剂作为细胞内质粒DNA递送的潜在低聚物候选物。
RSC Adv. 2024 Oct 15;14(44):32637-32647. doi: 10.1039/d4ra05978f. eCollection 2024 Oct 9.
8
Targeting senescence-associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes.靶向衰老相关 secretory phenotypes 重塑肿瘤微环境并调节肿瘤结局。
Clin Transl Med. 2024 Sep;14(9):e1772. doi: 10.1002/ctm2.1772.
9
Hepatitis B virus X protein and TGF-β: partners in the carcinogenic journey of hepatocellular carcinoma.乙型肝炎病毒X蛋白与转化生长因子-β:肝细胞癌致癌进程中的伙伴
Front Oncol. 2024 Jun 19;14:1407434. doi: 10.3389/fonc.2024.1407434. eCollection 2024.
10
Senescence Promotes the Recovery of Stemness among Cancer Cells via Reprograming.衰老通过重编程促进癌细胞干性的恢复。
Biomolecules. 2024 Feb 28;14(3):288. doi: 10.3390/biom14030288.
二甲双胍作为一种衰老抑制剂,可增强 CDK4/6 抑制剂在头颈部鳞状细胞癌中的抗癌疗效。
Cell Death Dis. 2020 Oct 28;11(10):925. doi: 10.1038/s41419-020-03126-0.
4
Non-canonical ATM/MRN activities temporally define the senescence secretory program.非典型 ATM/MRN 活性在时间上定义了衰老分泌程序。
EMBO Rep. 2020 Oct 5;21(10):e50718. doi: 10.15252/embr.202050718. Epub 2020 Aug 12.
5
Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies.衰老与癌症:衰老及衰老疗法临床意义综述
Cancers (Basel). 2020 Jul 31;12(8):2134. doi: 10.3390/cancers12082134.
6
Senescence as a therapeutically relevant response to CDK4/6 inhibitors.衰老作为对CDK4/6抑制剂的一种与治疗相关的反应。
Oncogene. 2020 Jul;39(29):5165-5176. doi: 10.1038/s41388-020-1354-9. Epub 2020 Jun 15.
7
The bright and dark side of extracellular vesicles in the senescence-associated secretory phenotype.细胞外囊泡在衰老相关分泌表型中的光明与黑暗面。
Mech Ageing Dev. 2020 Jul;189:111263. doi: 10.1016/j.mad.2020.111263. Epub 2020 May 24.
8
BH3 mimetics selectively eliminate chemotherapy-induced senescent cells and improve response in TP53 wild-type breast cancer.BH3 模拟物选择性消除化疗诱导的衰老细胞,提高 TP53 野生型乳腺癌的反应。
Cell Death Differ. 2020 Nov;27(11):3097-3116. doi: 10.1038/s41418-020-0564-6. Epub 2020 May 26.
9
Identification of SYK inhibitor, R406 as a novel senolytic agent.鉴定 SYK 抑制剂 R406 为一种新型的衰老细胞选择性清除剂。
Aging (Albany NY). 2020 May 7;12(9):8221-8240. doi: 10.18632/aging.103135.
10
Preclinical antitumor efficacy of senescence-inducing chemotherapy combined with a nanoSenolytic.诱导衰老化疗联合纳米 Senolytic 的临床前抗肿瘤疗效。
J Control Release. 2020 Jul 10;323:624-634. doi: 10.1016/j.jconrel.2020.04.045. Epub 2020 May 4.